心臟节律器市场－全球产业规模、份额、趋势、机会和预测，按类型、技术、产品类型、应用、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球心臟节律器市场规模为51亿美元，预计2030年将以4.47%的复合年增长率成长至66.3亿美元。心臟起搏器是一种植入式医疗设备，旨在产生电脉衝，从而调节异常心律。全球心臟起搏器市场的成长主要受心血管疾病在全球范围内日益普遍以及老年人口不断增长的推动，因为高龄是心律不整的主要风险因素。此外，设备的微型化、电池寿命的延长以及远端监测功能的整合等技术的不断进步也进一步推动了市场成长。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球心臟节律器市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依类型（植入式、体外）
  • 依技术类型（双腔、单腔、双心室）
  • 依产品类型（MRI兼容型、传统型）
  • 依应用领域（心律不整、充血性心臟衰竭、其他）
  • 依最终使用者（医院、心臟护理中心、门诊手术中心）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美心臟节律器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲心臟节律器市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区心臟节律器市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲心臟节律器市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美心臟节律器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球心臟节律器市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Medtronic PLC
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• Sorin Group
• Abbott Laboratories Inc.
• Edwards Lifesciences Corporation
• B. Braun Melsungen AG
• Osypka Medical GmbH
• Medico SpA
• Oscor, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Pacemaker Market, valued at USD 5.10 Billion in 2024, is projected to experience a CAGR of 4.47% to reach USD 6.63 Billion by 2030. A pacemaker is an implanted medical device designed to generate electrical impulses, thereby regulating abnormal heart rhythms. The global pacemaker market's growth is primarily driven by the increasing worldwide prevalence of cardiovascular diseases and the expanding geriatric population, as advanced age is a key risk factor for cardiac arrhythmias. Further impetus comes from continuous technological advancements, including device miniaturization, enhanced battery longevity, and integrated remote monitoring capabilities.

Key Market Drivers

The rising prevalence of cardiovascular diseases serves as a fundamental driver for the global pacemaker market. Cardiac conditions, particularly those involving rhythm disorders such as bradycardia, frequently necessitate pacemaker implantation to restore and maintain proper heart function. This increasing disease burden is observable globally, creating a continuous demand for advanced cardiac rhythm management solutions. According to a new study published in JACC, January 2024, 'New Study Reveals Latest Data on Global Burden of Cardiovascular Disease', global death counts attributed to cardiovascular disease rose to 19.8 million in 2022. The persistent rise in these complex conditions underscores the critical need for effective interventions, directly expanding the patient pool eligible for pacemaker therapy.

Key Market Challenges

The elevated cost of advanced pacemaker devices and associated implantation procedures presents a significant impediment to the global pacemaker market's expansion. This financial barrier directly restricts patient accessibility and affordability, particularly in regions with developing healthcare infrastructures and lower per capita income. The high upfront investment required for these medical devices, coupled with the expenses of specialized surgical procedures and ongoing follow-up care, creates a substantial economic burden for healthcare systems and individual patients alike.

Key Market Trends

The global pacemaker market is significantly influenced by the growing adoption of leadless pacemakers. These miniaturized devices, implanted directly into the heart without leads or a surgical pocket, reduce the risk of complications associated with traditional transvenous systems. For instance, a March 2024 summary by the American College of Cardiology highlighted a post-approval registry finding that Micra leadless pacemakers had a major complication rate of 4.1% at 36 months, which was significantly lower than the 8.5% observed for transvenous systems. This reduction in complications contributes to improved patient outcomes and expanded indications for leadless therapy.

Key Market Players

• Medtronic PLC
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• Sorin Group
• Abbott Laboratories Inc.
• Edwards Lifesciences Corporation
• B. Braun Melsungen AG
• Osypka Medical GmbH
• Medico S.p.A
• Oscor, Inc.

Report Scope:

In this report, the Global Pacemaker Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pacemaker Market, By Type:

• Implantable
• External

Pacemaker Market, By Technology:

• Dual Chamber
• Single Chamber
• Biventricular Chamber

Pacemaker Market, By Product Type:

• MRI Compatible
• Conventional

Pacemaker Market, By Applications:

• Arrythmias
• Congestive Heart Failure
• Others

Pacemaker Market, By End User:

• Hospitals
• Cardiac Care Centers
• Ambulatory Surgical Centers

Pacemaker Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pacemaker Market.

Available Customizations:

Global Pacemaker Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pacemaker Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Implantable, External)
  • 5.2.2. By Technology (Dual Chamber, Single Chamber, Biventricular Chamber)
  • 5.2.3. By Product Type (MRI Compatible, Conventional)
  • 5.2.4. By Applications (Arrythmias, Congestive Heart Failure, Others)
  • 5.2.5. By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Pacemaker Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Product Type
  • 6.2.4. By Applications
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pacemaker Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Product Type
      • 6.3.1.2.4. By Applications
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Pacemaker Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Product Type
      • 6.3.2.2.4. By Applications
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Pacemaker Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Product Type
      • 6.3.3.2.4. By Applications
      • 6.3.3.2.5. By End User

7. Europe Pacemaker Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Product Type
  • 7.2.4. By Applications
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pacemaker Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Product Type
      • 7.3.1.2.4. By Applications
      • 7.3.1.2.5. By End User
  • 7.3.2. France Pacemaker Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Product Type
      • 7.3.2.2.4. By Applications
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Pacemaker Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Product Type
      • 7.3.3.2.4. By Applications
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Pacemaker Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Product Type
      • 7.3.4.2.4. By Applications
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Pacemaker Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Product Type
      • 7.3.5.2.4. By Applications
      • 7.3.5.2.5. By End User

8. Asia Pacific Pacemaker Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Product Type
  • 8.2.4. By Applications
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pacemaker Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Product Type
      • 8.3.1.2.4. By Applications
      • 8.3.1.2.5. By End User
  • 8.3.2. India Pacemaker Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Product Type
      • 8.3.2.2.4. By Applications
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Pacemaker Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Product Type
      • 8.3.3.2.4. By Applications
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Pacemaker Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Product Type
      • 8.3.4.2.4. By Applications
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Pacemaker Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Product Type
      • 8.3.5.2.4. By Applications
      • 8.3.5.2.5. By End User

9. Middle East & Africa Pacemaker Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Product Type
  • 9.2.4. By Applications
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pacemaker Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Product Type
      • 9.3.1.2.4. By Applications
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Pacemaker Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Product Type
      • 9.3.2.2.4. By Applications
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Pacemaker Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Product Type
      • 9.3.3.2.4. By Applications
      • 9.3.3.2.5. By End User

10. South America Pacemaker Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Product Type
  • 10.2.4. By Applications
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pacemaker Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Product Type
      • 10.3.1.2.4. By Applications
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Pacemaker Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Product Type
      • 10.3.2.2.4. By Applications
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Pacemaker Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Product Type
      • 10.3.3.2.4. By Applications
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pacemaker Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic PLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boston Scientific Corporation
• 15.3. BIOTRONIK SE & Co. KG
• 15.4. Sorin Group
• 15.5. Abbott Laboratories Inc.
• 15.6. Edwards Lifesciences Corporation
• 15.7. B. Braun Melsungen AG
• 15.8. Osypka Medical GmbH
• 15.9. Medico S.p.A
• 15.10. Oscor, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer